Cargando…
Plasma Biomarkers of Reticular Pseudodrusen and the Risk of Progression to Advanced Age-Related Macular Degeneration
PURPOSE: To determine, using an aptamer-based technology in patients with intermediate age-related macular degeneration (AMD), (1) if there is a difference in plasma levels of 4979 proteins in patients with and without reticular pseudodrusen (RPD), and (2) if plasma levels of proteins are related to...
Autores principales: | Lynch, Anne M., Wagner, Brandie D., Palestine, Alan G., Janjic, Nebojsa, Patnaik, Jennifer L., Mathias, Marc T., Siringo, Frank S., Mandava, Naresh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488626/ https://www.ncbi.nlm.nih.gov/pubmed/32974084 http://dx.doi.org/10.1167/tvst.9.10.12 |
Ejemplares similares
-
Complement factors and reticular pseudodrusen in intermediate age-related macular degeneration staged by multimodal imaging
por: Lynch, Anne M, et al.
Publicado: (2020) -
Proteomic Profiles in Advanced Age-Related Macular Degeneration Using an Aptamer-Based Proteomic Technology
por: Lynch, Anne M., et al.
Publicado: (2019) -
Plasma C-C Chemokine Concentrations in Intermediate Age-Related Macular Degeneration
por: Palestine, Alan G., et al.
Publicado: (2021) -
Increased Systemic C-Reactive Protein Is Associated With Choroidal Thinning in Intermediate Age-Related Macular Degeneration
por: Chen, Rachel C., et al.
Publicado: (2021) -
Sex Differences in RANTES (CCL5) in Patients With Intermediate Age-Related Macular Degeneration (AMD) and Controls With no AMD
por: Fonteh, Cheryl N., et al.
Publicado: (2022)